Mackay Shields LLC Takes Position in Stepan (NYSE:SCL)

Mackay Shields LLC purchased a new position in Stepan (NYSE:SCL) during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 11,500 shares of the basic materials company’s stock, valued at approximately $851,000. Mackay Shields LLC owned about 0.05% of Stepan at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently made changes to their positions in the stock. BlackRock Inc. increased its position in Stepan by 2.8% in the 4th quarter. BlackRock Inc. now owns 2,976,582 shares of the basic materials company’s stock valued at $220,267,000 after acquiring an additional 81,517 shares during the period. Vanguard Group Inc. increased its position in shares of Stepan by 1.3% during the 3rd quarter. Vanguard Group Inc. now owns 2,227,810 shares of the basic materials company’s stock valued at $193,841,000 after purchasing an additional 28,876 shares during the period. Vanguard Group Inc increased its position in shares of Stepan by 1.3% during the 3rd quarter. Vanguard Group Inc now owns 2,227,810 shares of the basic materials company’s stock valued at $193,841,000 after purchasing an additional 28,876 shares during the period. Dimensional Fund Advisors LP increased its position in shares of Stepan by 0.3% during the 4th quarter. Dimensional Fund Advisors LP now owns 1,097,483 shares of the basic materials company’s stock valued at $81,214,000 after purchasing an additional 3,653 shares during the period. Finally, Bank of New York Mellon Corp increased its position in shares of Stepan by 0.4% during the 3rd quarter. Bank of New York Mellon Corp now owns 416,778 shares of the basic materials company’s stock valued at $36,265,000 after purchasing an additional 1,684 shares during the period. 72.34% of the stock is currently owned by institutional investors and hedge funds.

Several brokerages have recently issued reports on SCL. Zacks Investment Research upgraded Stepan from a “sell” rating to a “hold” rating in a research report on Friday, February 15th. ValuEngine cut Stepan from a “buy” rating to a “hold” rating in a research report on Thursday, March 21st. Four research analysts have rated the stock with a hold rating and one has given a buy rating to the stock. Stepan presently has a consensus rating of “Hold” and an average price target of $74.50.

Shares of SCL traded down $0.37 during trading hours on Friday, hitting $89.90. 67,795 shares of the company were exchanged, compared to its average volume of 79,999. The firm has a market cap of $2.03 billion, a PE ratio of 18.42 and a beta of 1.27. The company has a quick ratio of 1.78, a current ratio of 2.37 and a debt-to-equity ratio of 0.30. Stepan has a one year low of $68.09 and a one year high of $95.32.

Stepan (NYSE:SCL) last released its quarterly earnings data on Thursday, February 21st. The basic materials company reported $1.02 earnings per share for the quarter, topping the consensus estimate of $0.81 by $0.21. The business had revenue of $466.70 million during the quarter, compared to analyst estimates of $486.67 million. Stepan had a return on equity of 14.68% and a net margin of 5.66%. The company’s revenue was down 1.5% compared to the same quarter last year. During the same period last year, the company posted $1.06 EPS. On average, equities research analysts anticipate that Stepan will post 5.08 EPS for the current fiscal year.

In other news, VP Arthur W. Mergner sold 1,038 shares of the firm’s stock in a transaction on Thursday, March 7th. The stock was sold at an average price of $90.01, for a total transaction of $93,430.38. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Chairman F Quinn Stepan, Jr. sold 12,889 shares of the firm’s stock in a transaction on Friday, March 1st. The stock was sold at an average price of $93.83, for a total value of $1,209,374.87. Following the completion of the sale, the chairman now directly owns 202,576 shares of the company’s stock, valued at approximately $19,007,706.08. The disclosure for this sale can be found here. Over the last three months, insiders have bought 500 shares of company stock valued at $45,141 and have sold 17,927 shares valued at $1,664,845. Company insiders own 11.40% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “Mackay Shields LLC Takes Position in Stepan (NYSE:SCL)” was originally reported by Baseball Daily News and is owned by of Baseball Daily News. If you are accessing this story on another site, it was illegally stolen and reposted in violation of international copyright legislation. The legal version of this story can be viewed at https://www.baseballdailydigest.com/news/2019/04/21/mackay-shields-llc-purchases-new-stake-in-stepan-scl.html.

Stepan Profile

Stepan Company, together with its subsidiaries, produces and sells specialty and intermediate chemicals to other manufacturers for use in various end products in North America, Europe, Latin America, and Asia. The company operates through three segments: Surfactants, Polymers, and Specialty Products.

Featured Article: What is a conference call?

Institutional Ownership by Quarter for Stepan (NYSE:SCL)

Receive News & Ratings for Stepan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stepan and related companies with MarketBeat.com's FREE daily email newsletter.